0000950170-23-021785.txt : 20230512 0000950170-23-021785.hdr.sgml : 20230512 20230512161655 ACCESSION NUMBER: 0000950170-23-021785 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230512 DATE AS OF CHANGE: 20230512 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 23915987 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Foley Mark J CENTRAL INDEX KEY: 0001529196 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: ZELTIQ AESTHETICS INC. STREET 2: 4698 WILLOW ROAD SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 144 1 primary_doc.xml 144 0001529196 XXXXXXXX LIVE 0001479290 Revance Therapeutics, Inc. 001-36297 1222 Demonbreun St Suite 2000 Nashville TN 37203 615-724-7755 Mark Foley Officer COMMON E*TRADE FINANCIAL CORPORATION

3 EDISON DRIVE ALPHARETTA GA 30005

70000 2338000 84000000 05/12/2023 NASD Revance Common 05/11/2023 RSU Vesting Revance Therapeutics N 70000 05/11/2023 cash N Mark Foley

1222 Demonbreun St Suite 2000 Nashville TN 37203

Revance Common 03/09/2023 70390 2223360 Shares sold to cover taxes from a RSU vest 05/12/2023 Mark Foley